Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
25
11
2020
accepted:
28
05
2021
pubmed:
8
6
2021
medline:
5
8
2021
entrez:
7
6
2021
Statut:
ppublish
Résumé
Following its emergence in late 2019, the spread of SARS-CoV-2
Identifiants
pubmed: 34098568
doi: 10.1038/s41586-021-03677-y
pii: 10.1038/s41586-021-03677-y
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
707-712Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM120553
Pays : United States
Organisme : NIAID NIH HHS
ID : DP1 AI158186
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI141707
Pays : United States
Organisme : NIAID NIH HHS
ID : F30 AI149928
Pays : United States
Investigateurs
Fernando González-Candelas
(F)
Galo Adrian Goig
(GA)
Álvaro Chiner-Oms
(Á)
Irving Cancino-Muñoz
(I)
Mariana Gabriela López
(MG)
Manuela Torres-Puente
(M)
Inmaculada Gomez-Navarro
(I)
Santiago Jiménez-Serrano
(S)
Lidia Ruiz-Roldán
(L)
María Alma Bracho
(MA)
Neris García-González
(N)
Llúcia Martínez-Priego
(L)
Inmaculada Galán-Vendrell
(I)
Paula Ruiz-Hueso
(P)
Griselda De Marco
(G)
Maria Loreto Ferrús
(ML)
Sandra Carbó-Ramírez
(S)
Giuseppe D'Auria
(G)
Mireia Coscollá
(M)
Paula Ruiz-Rodríguez
(P)
Francisco Javier Roig-Sena
(FJ)
Isabel Sanmartín
(I)
Daniel Garcia-Souto
(D)
Ana Pequeno-Valtierra
(A)
Jose M C Tubio
(JMC)
Jorge Rodríguez-Castro
(J)
Nuria Rabella
(N)
Ferrán Navarro
(F)
Elisenda Miró
(E)
Manuel Rodríguez-Iglesias
(M)
Fátima Galán-Sanchez
(F)
Salud Rodriguez-Pallares
(S)
María de Toro
(M)
María Bea Escudero
(MB)
José Manuel Azcona-Gutiérrez
(JM)
Miriam Blasco Alberdi
(MB)
Alfredo Mayor
(A)
Alberto L García-Basteiro
(AL)
Gemma Moncunill
(G)
Carlota Dobaño
(C)
Pau Cisteró
(P)
Darío García-de-Viedma
(D)
Laura Pérez-Lago
(L)
Marta Herranz
(M)
Jon Sicilia
(J)
Pilar Catalán-Alonso
(P)
Patricia Muñoz
(P)
Cristina Muñoz-Cuevas
(C)
Guadalupe Rodríguez-Rodríguez
(G)
Juan Alberola-Enguidanos
(J)
Jose Miguel Nogueira
(JM)
Juan José Camarena
(JJ)
Antonio Rezusta
(A)
Alexander Tristancho-Baró
(A)
Ana Milagro
(A)
Nieves Felisa Martínez-Cameo
(NF)
Yolanda Gracia-Grataloup
(Y)
Elisa Martró
(E)
Antoni E Bordoy
(AE)
Anna Not
(A)
Adrián Antuori-Torres
(A)
Rafael Benito
(R)
Sonia Algarate
(S)
Jessica Bueno
(J)
Jose Luis Del Pozo
(JL)
Jose Antonio Boga
(JA)
Cristián Castelló-Abietar
(C)
Susana Rojo-Alba
(S)
Marta Elena Alvarez-Argüelles
(ME)
Santiago Melon
(S)
Maitane Aranzamendi-Zaldumbide
(M)
Andrea Vergara-Gómez
(A)
Jovita Fernández-Pinero
(J)
Miguel J Martínez
(MJ)
Jordi Vila
(J)
Elisa Rubio
(E)
Aida Peiró-Mestres
(A)
Jessica Navero-Castillejos
(J)
David Posada
(D)
Diana Valverde
(D)
Nuria Estévez-Gómez
(N)
Iria Fernandez-Silva
(I)
Loretta de Chiara
(L)
Pilar Gallego-García
(P)
Nair Varela
(N)
Rosario Moreno
(R)
Maria Dolores Tirado
(MD)
Ulises Gomez-Pinedo
(U)
Mónica Gozalo-Margüello
(M)
Maria Eliecer-Cano
(M)
José Manuel Méndez-Legaza
(JM)
Jesus Rodríguez-Lozano
(J)
María Siller
(M)
Daniel Pablo-Marcos
(D)
Antonio Oliver
(A)
Jordi Reina
(J)
Carla López-Causapé
(C)
Andrés Canut-Blasco
(A)
Silvia Hernáez-Crespo
(S)
Maria Luz A Cordón
(MLA)
María-Concepción Lecároz-Agara
(MC)
Carmen Gómez-González
(C)
Amaia Aguirre-Quiñonero
(A)
José Israel López-Mirones
(JI)
Marina Fernández-Torres
(M)
Maria Rosario Almela-Ferrer
(MR)
Nieves Gonzalo-Jiménez
(N)
Maria Montserrat Ruiz-García
(MM)
Antonio Galiana
(A)
Judith Sanchez-Almendro
(J)
Gustavo Cilla
(G)
Milagrosa Montes
(M)
Luis Piñeiro
(L)
Ane Sorarrain
(A)
José María Marimón
(JM)
Maria Dolores Gomez-Ruiz
(MD)
José Luis López-Hontangas
(JL)
Eva M González Barberá
(EM)
José María Navarro-Marí
(JM)
Irene Pedrosa-Corral
(I)
Sara Sanbonmatsu-Gámez
(S)
Carmen Pérez-González
(C)
Francisco Chamizo-López
(F)
Ana Bordes-Benítez
(A)
David Navarro
(D)
Eliseo Albert
(E)
Ignacio Torres
(I)
Isabel Gascón
(I)
Cristina Juana Torregrosa-Hetland
(CJ)
Eva Pastor-Boix
(E)
Paloma Cascales-Ramos
(P)
Begoña Fuster-Escrivá
(B)
Concepción Gimeno-Cardona
(C)
María Dolores Ocete
(MD)
Rafael Medina-Gonzalez
(R)
Julia González-Cantó
(J)
Olalla Martínez-Macias
(O)
Begoña Palop-Borrás
(B)
Inmaculada de Toro
(I)
Maria Concepción Mediavilla-Gradolph
(MC)
Mercedes Pérez-Ruiz
(M)
Óscar González-Recio
(Ó)
Mónica Gutiérrez-Rivas
(M)
Encarnación Simarro-Córdoba
(E)
Julia Lozano-Serra
(J)
Lorena Robles-Fonseca
(L)
Adolfo de Salazar
(A)
Laura Viñuela-González
(L)
Natalia Chueca
(N)
Federico García
(F)
Cristina Gómez-Camarasa
(C)
Ana Carvajal
(A)
Raul de la Puente
(R)
Vicente Martín-Sánchez
(V)
Juan-Miguel Fregeneda-Grandes
(JM)
Antonio José Molina
(AJ)
Héctor Argüello
(H)
Tania Fernández-Villa
(T)
Maria Amparo Farga-Martí
(MA)
Victoria Domínguez-Márquez
(V)
José Javier Costa-Alcalde
(JJ)
Rocío Trastoy
(R)
Gema Barbeito-Castiñeiras
(G)
Amparo Coira
(A)
María Luisa Pérez-Del-Molino
(ML)
Antonio Aguilera
(A)
Anna M Planas
(AM)
Alex Soriano
(A)
Israel Fernandez-Cádenas
(I)
Jordi Pérez-Tur
(J)
Maria Ángeles Marcos
(MÁ)
Antonio Moreno-Docón
(A)
Esther Viedma
(E)
Jesús Mingorance
(J)
Juan Carlos Galán-Montemayor
(JC)
Mónica Parra-Grande
(M)
Commentaires et corrections
Type : UpdateOf
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Références
WHO Emergency Committee. Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (2020).
Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
doi: 10.1056/NEJMoa2001017
Worobey, M. et al. The emergence of SARS-CoV-2 in Europe and North America. Science 370, 564–570 (2020).
doi: 10.1126/science.abc8169
Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121–4123 (2018).
doi: 10.1093/bioinformatics/bty407
du Plessis, L. et al. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science 371, 708–712 (2021).
doi: 10.1126/science.abf2946
Shu, Y. & McCauley, J. GISAID: global initiative on sharing all influenza data — from vision to reality. Euro Surveill. 22, 30494 (2017).
doi: 10.2807/1560-7917.ES.2017.22.13.30494
Korber, B. et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182, 812–827.e19 (2020).
doi: 10.1016/j.cell.2020.06.043
Volz, E. et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell 184, 64–75.e11 (2020).
doi: 10.1016/j.cell.2020.11.020
Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592, 116–121 (2021).
doi: 10.1038/s41586-020-2895-3
Yurkovetskiy, L. et al. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell 183, 739–751.e8 (2020).
doi: 10.1016/j.cell.2020.09.032
Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 372, eabg3055 (2021).
doi: 10.1126/science.abg3055
Volz, E. et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 593, 266–269 (2021).
doi: 10.1038/s41586-021-03470-x
Pearson, C. A. B. et al. Estimates of severity and transmissibility of novel SARS-CoV-2 variant 501Y.V2 in South Africa. Preprint at https://cmmid.github.io/topics/covid19/sa-novel-variant.html (2021).
Tegally, H. et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 592, 438–443 (2021).
doi: 10.1038/s41586-021-03402-9
Sabino, E. C. et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet 397, 452–455 (2021).
doi: 10.1016/S0140-6736(21)00183-5
Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 5, 1403–1407 (2020).
doi: 10.1038/s41564-020-0770-5
Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682–687 (2020).
doi: 10.1038/s41586-020-2852-1
Tortorici, M. A. et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science 370, 950–957 (2020).
doi: 10.1126/science.abe3354
Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell 184, 1171–1187 (2021).
doi: 10.1016/j.cell.2021.01.037
McCallum, M., Walls, A. C., Bowen, J. E., Corti, D. & Veesler, D. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat. Struct. Mol. Biol. 27, 942–949 (2020).
doi: 10.1038/s41594-020-0483-8
Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e6 (2020).
doi: 10.1016/j.cell.2020.02.058
Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290–295 (2020).
doi: 10.1038/s41586-020-2349-y
Walls, A. C. et al. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Cell 183, 1367–1382.e17 (2020).
doi: 10.1016/j.cell.2020.10.043
Chi, X. et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science 369, 650–655 (2020).
doi: 10.1126/science.abc6952
McCallum, M. et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell 184, 2332–2347.e16 (2021).
doi: 10.1016/j.cell.2021.03.028
Finkel, Y. et al. The coding capacity of SARS-CoV-2. Nature 589, 125–130 (2021).
doi: 10.1038/s41586-020-2739-1
Pancer, K. et al. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans. PLoS Pathog. 16, e1008959 (2020).
doi: 10.1371/journal.ppat.1008959
Grubaugh, N. D., Hanage, W. P. & Rasmussen, A. L. Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear. Cell 182, 794–795 (2020).
doi: 10.1016/j.cell.2020.06.040
Instituto Nacional de Estadistica. Hotel Industry and Tourism – Tourist Movement on Borders Survey Frontur. (accessed December 2020); https://www.ine.es/dyngs/INEbase/en/operacion.htm?c=Estadistica_C&cid=1254736176996&menu=resultados&secc=1254736195568&idp=1254735576863
Aena.es. Air Traffic Statistics (accessed January 2021); https://portal.aena.es/en/corporate/air-traffic-statistics.html
Correa-Martínez, C. L. et al. A pandemic in times of global tourism: superspreading and exportation of COVID-19 cases from a ski area in austria. J. Clin. Microbiol. 58, e00588-20 (2020).
doi: 10.1128/JCM.00588-20
Knabl, L. et al. High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort Ischgl. Preprint at https://doi.org/10.1101/2020.08.20.20178533 (2020).
Mossong, J. et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 5, e74 (2008).
doi: 10.1371/journal.pmed.0050074
Jarvis, C. I. et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med. 18, 124 (2020).
doi: 10.1186/s12916-020-01597-8
Neher, R. A., Dyrdak, R., Druelle, V., Hodcroft, E. B. & Albert, J. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Swiss Med. Wkly. 150, w20224 (2020).
pubmed: 32176808
Lauring, A. S. & Hodcroft, E. B. Genetic variants of SARS-CoV-2—what do they mean? J. Am. Med. Assoc. 325, 529–531 (2021).
doi: 10.1001/jama.2020.27124
Katoh, K., Misawa, K., Kuma, K. & Miyata, T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 30, 3059–3066 (2002).
doi: 10.1093/nar/gkf436
Minh, B. Q. et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 37, 1530–1534 (2020).
doi: 10.1093/molbev/msaa015
Sagulenko, P., Puller, V. & Neher, R. A. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 4, vex042 (2018).
doi: 10.1093/ve/vex042
Nadeau, S. et al. Quantifying SARS-CoV-2 spread in Switzerland based on genomic sequencing data. Preprint at https://doi.org/10.1101/2020.10.14.20212621 (2020).
Stange, M. et al. SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to mass gathering events. PLOS Pathog. 17, e1009374 (2021).
doi: 10.1371/journal.ppat.1009374
Robert Koch Institute. Aktueller Lage-/Situationsbericht des RKI zu COVID-19 https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Gesamt.html (2020).
Stadler, T., Kühnert, D., Bonhoeffer, S. & Drummond, A. J. Birth-death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV). Proc. Natl Acad. Sci. USA 110, 228–233 (2013).
doi: 10.1073/pnas.1207965110
Bouckaert, R. et al. BEAST 2.5: an advanced software platform for Bayesian evolutionary analysis. PLOS Comput. Biol. 15, e1006650 (2019).
doi: 10.1371/journal.pcbi.1006650
Pallesen, J. et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl Acad. Sci. USA 114, E7348–E7357 (2017).
doi: 10.1073/pnas.1707304114
Greaney, A. J. et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29, 44–57.e9 (2021).
doi: 10.1016/j.chom.2020.11.007
Crawford, K. H. D. et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses 12, 513 (2020).
doi: 10.3390/v12050513